| Descriptor English: | Lobeline | ||||
| Descriptor Spanish: |
Lobelina
| ||||
| Descriptor Portuguese: | Lobelina | ||||
| Descriptor French: | Lobéline | ||||
| Entry term(s): |
Lobeline Sulfate Smokeless Sulfate, Lobeline |
||||
| Tree number(s): |
D03.132.478 D03.383.621.418 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008120 | ||||
| Scope note: | An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation. |
||||
| Annotation: | /biosyn permitted if by plant |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Ganglionic Stimulants Nicotinic Agonists Respiratory System Agents |
||||
| Registry Number: | D0P25S3P81 | ||||
| CAS Type 1 Name: | Ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, (2R-(2alpha,6alpha(S*)))- | ||||
| DeCS ID: | 8297 | ||||
| Unique ID: | D008120 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1966/01/01 | ||||
| Date of Entry: | 1999/01/01 | ||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Lobeline
- Preferred
Smokeless
- Narrower
Lobeline Sulfate
- Narrower
| Concept UI |
M0012663 |
| Scope note | An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation. |
| Preferred term | Lobeline |
| Concept UI |
M0463947 |
| Preferred term | Smokeless |
| Concept UI |
M0463946 |
| Preferred term | Lobeline Sulfate |
| Entry term(s) |
Sulfate, Lobeline |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey